Speaker Interviews

2016

Enhancing the Efficacy of Checkpoint Inhibition with a TLR9 Agonist Delivered in a Virus-Like Particle
with Arthur M. Krieg, M.D. CEO, Checkmate Pharmaceuticals

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag

Register Today
Celebrating 25 Years



2017 Download Brochure


IPR_IMX_Banner